Pfizer Total Long-Term Assets 2012-2026 | PFE

Pfizer total long-term assets for the quarter ending March 31, 2026 were $161.807B, a 8.2% decline year-over-year.

  • Pfizer total long-term assets for 2024 were $163.037B, a 10.99% decline from 2023.
  • Pfizer total long-term assets for 2023 were $183.168B, a 25.51% increase from 2022.
  • Pfizer total long-term assets for 2022 were $145.944B, a 19.84% increase from 2021.

Pfizer Total Long-Term Assets 2012-2026 | PFE

  • Pfizer total long-term assets for 2024 were $163.037B, a 10.99% decline from 2023.
  • Pfizer total long-term assets for 2023 were $183.168B, a 25.51% increase from 2022.
  • Pfizer total long-term assets for 2022 were $145.944B, a 19.84% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B